“…However, studies have been small and inconsistent. 8,9 Propranolol, 10 a beta adrenergic receptor blocker; irbesartan, 11 an angiotensin-II receptor blocker; demeclocycline, 12 a tetracycline that inhibits antidiuretic hormone action; and naltrexone, 9 a mu opioid antagonist, have been studied with inconclusive results and a variety of adverse effects 5,7,13 (Table 2 [8][9][10][11][12][13] ).…”